FluoroPharma Medical, Inc.

FPMIOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$6852

P/E Ratio—

52W High$0.0002

52W Low$0.0001

Avg Volume336

Open$0.00

Beta-69.72

Earnings Financials Revenue

FluoroPharma Medical, Inc. (FPMI) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

FPMI · earnings · updated Jun 8, 2026

Latest Earnings

Q1 FY2017Report Date: Mar 31, 2017

EPS Actual

-$0.01

Revenue

—

Fiscal Period

Q1 FY2017

FY ends December

Report Date

Mar 31, 2017

After Market Close

✓ 3-Quarter EPS Beat Streak

FPMI reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q1 FY2017	Mar 31, 2017	—	-$0.01	—	—	—	—
— Q4 FY2016	Dec 31, 2016	—	-$0.00	—	—	—	—
— Q4 FY2016	Nov 14, 2016	—	-$0.01	—	—	—	—
— Q3 FY2016	Aug 15, 2016	—	-$0.03	—	—	—	—
— Q1 FY2016	Mar 30, 2016	—	-$0.04	—	—	—	—
▲ Q4 FY2015	Nov 16, 2015	-$0.06	-$0.04	+33.3%	—	—	—
— Q3 FY2015	Sep 30, 2015	—	$0.00	—	—	—	—
▲ Q3 FY2015	Aug 14, 2015	-$0.06	-$0.05	+16.7%	—	—	—

Q1 FY2017

Mar 31, 2017

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2016

Dec 31, 2016

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2016

Nov 14, 2016

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2016

Aug 15, 2016

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2016

Mar 30, 2016

EPS Actual

-$0.04

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2015

Nov 16, 2015Beat

EPS Actual

-$0.04

EPS Est.

-$0.06

EPS Surpr.

+33.3%

Revenue

—

Q3 FY2015

Sep 30, 2015

EPS Actual

$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2015

Aug 14, 2015Beat

EPS Actual

-$0.05

EPS Est.

-$0.06

EPS Surpr.

+16.7%

Revenue

—

No analyst estimates available for FPMI.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2017	Mar 31, 2017	—	$0.07	$0.07	+0.00%
— Q4 FY2016	Dec 31, 2016	—	$0.11	$0.13	+16.59%
— Q4 FY2016	Nov 14, 2016	—	$0.19	$0.16	-13.51%
— Q3 FY2016	Aug 15, 2016	—	$0.23	$0.24	+8.34%
— Q1 FY2016	Mar 30, 2016	—	$0.29	$0.27	-5.59%
▲ Q4 FY2015	Nov 16, 2015	+33.3%	$0.26	$0.26	+0.29%
— Q3 FY2015	Sep 30, 2015	—	$0.25	$0.28	+10.10%
▲ Q3 FY2015	Aug 14, 2015	+16.7%	$0.35	$0.35	+0.00%

Q1 FY2017+0.00%

Report Date

Mar 31, 2017

EPS Beat/Miss

—

Price Before

$0.07

Price After

$0.07

Q4 FY2016+16.59%

Report Date

Dec 31, 2016

EPS Beat/Miss

—

Price Before

$0.11

Price After

$0.13

Q4 FY2016-13.51%

Report Date

Nov 14, 2016

EPS Beat/Miss

—

Price Before

$0.19

Price After

$0.16

Q3 FY2016+8.34%

Report Date

Aug 15, 2016

EPS Beat/Miss

—

Price Before

$0.23

Price After

$0.24

Q1 FY2016-5.59%

Report Date

Mar 30, 2016

EPS Beat/Miss

—

Price Before

$0.29

Price After

$0.27

Q4 FY2015+0.29%

Report Date

Nov 16, 2015

EPS Beat/Miss

+33.3%

Price Before

$0.26

Price After

$0.26

Q3 FY2015+10.10%

Report Date

Sep 30, 2015

EPS Beat/Miss

—

Price Before

$0.25

Price After

$0.28

Q3 FY2015+0.00%

Report Date

Aug 14, 2015

EPS Beat/Miss

+16.7%

Price Before

$0.35

Price After

$0.35

Avg Beat Reaction+0.14%

Beat Rate2 / 8 quarters

Largest Move+16.59% (Q4 FY2016)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

FluoroPharma Medical, Inc. (FPMI) most recently reported earnings on March 31, 2017 for Q1 FY2017, posting EPS of $-0.01 (in line with the analyst consensus of —). FPMI has beaten EPS estimates for 3 consecutive quarters. The next FPMI earnings date is expected around September 1, 2026.

Each quarter, investors track FPMI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. FPMI revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

FPMI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

FPMI earnings · 4 questions

FluoroPharma Medical, Inc.'s next earnings report is expected around September 1, 2026. FPMI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; FPMI historically reports after market close (AMC).

FPMI earnings datewhen is FPMI earningsFPMI next earnings datewhen does FPMI report earningsFPMI earnings calendar

▸ Source: FMP · FluoroPharma Medical, Inc. SEC filings · US GAAP · FluoroPharma Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026